Roxithromycin EP Impurity C
CAS: 111321-02-9
Ref. 3D-FR166227
5mg | 194,00 € | ||
10mg | 310,00 € | ||
25mg | 472,00 € | ||
50mg | 646,00 € | ||
100mg | 986,00 € |
Información del producto
- Unii-10W452Cmtz
- Erythromycin, 9-oxime
- Erythromycin A Oxime
- (3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione 10-oxime (non-preferred name)
Roxithromycin EP Impurity C is a byproduct of the synthesis of erythromycin. It has been shown to have anti-inflammatory activity in liver cells, and has been used as a model for studying the mechanism of action of erythromycin. The reaction solution contains inorganic acid and nitrogen atoms. Roxithromycin EP Impurity C reacts with erythromycin to form an intermediate that then undergoes a series of reactions, including hydroxylation, oxidation, and decarboxylation. The purified product is made up of carbonyl groups and transcriptional regulation. This impurity can also be found in cell nuclei.
Propiedades químicas
Consulta técnica sobre: 3D-FR166227 Roxithromycin EP Impurity C
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.